Related Experiment Video
Updated: Jan 17, 2026
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Assessing the Need for Creating ICD-10 Codes to Enhance Monitoring of Doxycycline Postexposure Prophylaxis
Guoyu Tao1, Larry He, Chirag Patel1
1From the Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA.
Background:
In 2024, the Centers for Disease Control and Prevention recommended postexposure prophylaxis with doxycycline (doxy PEP) within 72 hours after sex for men who have sex with men and other selected populations diagnosed with one or more bacterial sexually transmitted infections (STIs) within the past 12 months. To determine if doxy PEP prescriptions can be identified using existing International Classification of Diseases, Tenth Revision ( ICD-10 ) codes, we assessed the utilization of several ICD-10 codes that document sexual behaviors and doxycycline prescriptions using a large electronic health record dataset.
Methods:
We used 2018-2023 Truveta electronic health record data to analyze encounters indicating increased risk for HIV/STI ( ICD-10 codes: Z72.53 [high-risk bisexual behavior], Z72.52 [high-risk homosexual behavior], Z20.6 [exposure to HIV], Z20.2 [exposure to infections with a predominantly sexual mode of transmission], and Z29.81 [encounter for HIV preexposure prophylaxis]) among men aged 15 to 60 years and stratified by doxycycline prescription within 14 days of the encounter.
Results:
Among 428,023 encounters coded for increased risk of HIV/STI among men aged 15 to 60 years, 78.2% were coded as Z20.2, followed by 10.4% as Z20.6, 9.9% as Z72.52, 1.2% as Z72.53, and 0.3% as Z29.81. The proportion of those encounters with doxycycline prescriptions was 16.1%. Among 68,891 encounters with doxycycline prescriptions, the top 5 ICD-10 codes associated an STI syndrome were symptoms of genitourinary system (R30-R39, 28.7%), diseases of urinary system (N30-N39, 9.9%), chlamydia (A74.9, 2.6%), gonorrhea (A54.9, 1.5%), and syphilis (A53.9, 1.2%), and the top 1 with a non-STI syndrome was asthma (J45, 5.9%).
Conclusions:
Before Centers for Disease Control and Prevention recommendations for doxy PEP, most encounters for potentially eligible patients were not explicitly among men who have sex with men, and doxycycline was prescribed broadly for various indications. A new ICD-10 code is needed for monitoring doxy PEP prescriptions with administrative data.
Related Concept Videos
01:19Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:28Dosage Regimens: Designs and Approaches
01:25Drug Regulation
01:02Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
01:22Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
01:16Therapeutic Drug Monitoring: Overview and Classification